@JacobFosterr 2 weeks ago
Diamond Hill Sees More Potential in BioLife Solutions
Diamond Hill Sees More Potential in BioLife Solutions
is getting fresh attention after Diamond Hill highlighted the company’s high switching costs and strong position in the biopreservation market. BioLife also reported 21% year-over-year revenue growth in Q2, adding to the bullish case. With the cell and gene therapy market continuing to expand, looks like an interesting small-cap healthcare name to watch. Do you think has more room to run, or is the opportunity already priced in?
@MasonCarter10 2 weeks ago
Strong growth and high switching costs make BioLife an interesting small-cap to watch.
@bennettOlivia7 1 week ago
Strong growth and high switching costs can be a pretty powerful combination, especially for a smaller company that still has room to scale.
